State Street SPDR S&P Biotech ETF
633 hedge funds and large institutions have $7.94B invested in State Street SPDR S&P Biotech ETF in 2021 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 224 increasing their positions, 185 reducing their positions, and 72 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $9.04B → $7.94B (-$1.1B)
24% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 72
54% less call options, than puts
Call options by funds: $1.5B | Put options by funds: $3.28B
Holders
633
Holding in Top 10
20
Calls
$1.5B
Puts
$3.28B
Top Buyers
| 1 | +$160M | |
| 2 | +$103M | |
| 3 | +$101M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$82.8M |
| 5 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$71.4M |
Top Sellers
| 1 | -$386M | |
| 2 | -$240M | |
| 3 | -$164M | |
| 4 |
Morgan Stanley
New York
|
-$81.5M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$75.4M |